Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells
article
OA: closed
CC0
⤵ 35 in-corpus citations
AI-generated summary
Lipoxin A4 modulates estrogen receptor expression and reduces 17β-estradiol-stimulated p38 MAPK phosphorylation in human endometriotic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo study the role of lipoxin A4 (LXA4) in endometriosis.DesignMolecular analysis in human samples and primary human endometriotic stromal cells (ESCs).SettingUniversity hospital.Patient(s)Forty-nine premenopausal women (30 patients with endometriosis and 19 controls).Intervention(s)Normal and ectopic endometrial biopsies obtained during surgery performed during the proliferative phase of the menstrual cycle; ESCs used for in vitro studies.Main outcome measure(s)Levels of LXA4 measured by enzyme-linked immunosorbent assay (ELISA); mRNA levels of the estrogen receptor (ER), progestogen receptor (PR), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) quantified by quantitative reverse-transcription polymerase chain reaction (qRT-PCR); and p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation evaluated by Western blotting.Result(s)The LXA4 expression level decreased in ectopic tissue as well as ERα and PR, although the expression of ERβ increased in ectopic endometrium compared with the controls. Investigations with correlation analysis revealed the expression of LXA4 was positively correlated with ERα and negatively correlated with ERβ in vivo. Moreover, administering LXA4 could augment ERβ expression in ESCs and inhibit the 17β-estradiol-induced phosphorylation of p38 MAPK very likely through ERβ.Conclusion(s)Our findings indicate that LXA4 regulates ERβ expression and inhibits 17β-estradiol-induced phosphorylation of p38 MAPK, very likely through ERβ in ESCs.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- 15-Epi-lipoxin A4 inhibits the progression of endometriosis in a murine model via openalex
- A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis via openalex
- Change profiles in matrix metalloproteinase-2 and -9 in induced endometriosis in mice via openalex
- Estrogen metabolism and action in endometriosis via openalex
- Estrogen Receptor (ER) β Regulates ERα Expression in Stromal Cells Derived from Ovarian Endometriosis via openalex
- Eutopic and ectopic stromal cells from patients with endometriosis exhibit differential invasive, adhesive, and proliferative behavior via openalex
- Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis via openalex
- FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model via openalex
- In Vivo Regulation of p38 MAPK Activation in Human Endometrium and Endometriosis via openalex
- Lipoxin <scp>A</scp>4 Inhibits the Development of Endometriosis in Mice: The Role of Anti‐Inflammation and Anti‐Angiogenesis via openalex
- Possible Pathophysiological Roles of Mitogen‐Activated Protein Kinases (MAPKs) in Endometriosis via openalex
- Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1 via openalex
- SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model via openalex
- The inhibitory effect of 15-R-LXA4 on experimental endometriosis via openalex
- The role of Lipoxin A4 in endometrial biology and endometriosis via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2114570899 via openalex
- W2116888004 via openalex
- W2146257792 via openalex
- W2159203244 via openalex
- W2408270560 via openalex
- W4211081176 via openalex
- W279493580 via openalex
- W6670469724 via openalex
- W1601517895 via openalex
- W1647868114 via openalex
- W1963996841 via openalex
- W1981495176 via openalex
- W1991455388 via openalex
- W1993354065 via openalex
- W2002480640 via openalex
- W2017735744 via openalex
- W2019198121 via openalex
- W2030292559 via openalex
- W2049619918 via openalex
- W2074102438 via openalex
- W2078462794 via openalex
- W2097930657 via openalex
- W2111790202 via openalex
Cited by (35)
- Integrated Proteomics Reveals Spliceosome Dysregulation and Highlights DHX9 as a TGF-β Signaling-Driven Fibrosis Hub in Endometriosis 2025
- Additional file 4 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 10 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 1 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 10 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 5 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 9 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 8 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 6 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 6 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 7 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 4 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 9 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 5 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 8 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 7 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 3 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 1 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 3 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 2 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- Additional file 2 of Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis 2024
- The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review 2021
- The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target 2021
- Lipoxin A4 inhibits the development of endometriosis in a mouse model by suppressing local estradiol synthesis 2020
- RhoA/ROCK pathway mediates the effect of oestrogen on regulating epithelial‐mesenchymal transition and proliferation in endometriosis 2020
- Circular RNA Expression Profiling and Bioinformatic Analysis of Cumulus Cells in Endometriosis Infertility Patients 2020
- Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPk Activation in Endometriosis 2019
- High expression of ZEB1 in endometriosis and its role in 17β-estradiol-induced epithelial-mesenchymal transition. 2018
- Long non‐coding RNA AFAP1‐AS1 promoting epithelial‐mesenchymal transition of endometriosis is correlated with transcription factor ZEB1 2018
- p38 Mitogen-Activated Protein Kinase is Involved in the Pathogenesis of Endometriosis by Modulating Inflammation, but not Cell Survival 2017
- Lipoxin A4 Suppresses Estrogen-Induced Epithelial-Mesenchymal Transition via ALXR-Dependent Manner in Endometriosis 2017
- Endometriosis: where are we and where are we going? 2016
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics 2016
- Serum Polyunsaturated Fatty Acids and Endometriosis 2014
Source provenance
- europepmc
- last seen: 2026-07-28T06:14:09.330459+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:29.016410+00:00
License: CC0
· commercial use OK